Lupus nephritis (LN) occurs in up to 40-50% of patients with systemic lupus erythematosus
(SLE). Renal involvement remains the strongest predictor of morbidity and mortality among …

Objective To evaluate long-term mortality and end-stage renal disease (ESRD) in a cohort of
Norwegian patients with biopsy-proven lupus nephritis (LN). Methods Renal biopsies were …

Abstract BACKGROUND AND AIMS Lupus nephritis (LN) is the most common severe
manifestation of systemic lupus erythematosus (SLE) and can lead to end-stage renal …

Background: Lupus nephritis (LN) is still associated with significant mortality and substantial
risk of progression to end-stage renal failure. Its outcome is related to the class and severity …

Objective To compare the risk of end-stage renal disease (ESRD) between patients with
early-onset lupus nephritis (EOLN) and those with delayed-onset LN (DOLN). Methods This …

Lupus nephritis (LN) is a common and severe manifestation of systemic lupus
erythematosus (SLE), which puts a substantial burden on patients living with the disease …

Objectives Lupus nephritis (LN) remains one of the most severe manifestations in patients
with systemic lupus erythematosus (SLE). Onset and overall LN risk among SLE patients …

Lupus nephritis remains the most prevalent complication of moderate-to-severe systemic
lupus erythematosus (SLE), affecting between 20% and 50% of patients with SLE, with …

Objectives Despite current advances in treatment, refractory lupus nephritis (RLN) continues
to pose a challenge. The present paper studies the clinical profile and treatment outcomes in …

Increased lupus nephritis has been reported in Pacific Island and Maori populations.
Previous studies suggest ethnic variation in response to immunosuppression treatment; …